Title |
Targeting EMT in cancer: opportunities for pharmacological intervention
|
---|---|
Published in |
Trends in Pharmacological Sciences, July 2014
|
DOI | 10.1016/j.tips.2014.06.006 |
Pubmed ID | |
Authors |
Felicity M. Davis, Teneale A. Stewart, Erik W. Thompson, Gregory R. Monteith |
Abstract |
The spread of cancer cells to distant organs represents a major clinical challenge in the treatment of cancer. Epithelial-mesenchymal transition (EMT) has emerged as a key regulator of metastasis in some cancers by conferring an invasive phenotype. As well as facilitating metastasis, EMT is thought to generate cancer stem cells and contribute to therapy resistance. Therefore, the EMT pathway is of great therapeutic interest in the treatment of cancer and could be targeted either to prevent tumor dissemination in patients at high risk of developing metastatic lesions or to eradicate existing metastatic cancer cells in patients with more advanced disease. In this review, we discuss approaches for the design of EMT-based therapies in cancer, summarize evidence for some of the proposed EMT targets, and review the potential advantages and pitfalls of each approach. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Canada | 1 | 25% |
Mexico | 1 | 25% |
United States | 1 | 25% |
United Kingdom | 1 | 25% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 75% |
Scientists | 1 | 25% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | <1% |
Iran, Islamic Republic of | 1 | <1% |
Brazil | 1 | <1% |
Unknown | 257 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 67 | 26% |
Researcher | 40 | 15% |
Student > Master | 31 | 12% |
Student > Bachelor | 29 | 11% |
Student > Doctoral Student | 13 | 5% |
Other | 43 | 16% |
Unknown | 38 | 15% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 77 | 30% |
Biochemistry, Genetics and Molecular Biology | 69 | 26% |
Medicine and Dentistry | 33 | 13% |
Engineering | 11 | 4% |
Pharmacology, Toxicology and Pharmaceutical Science | 10 | 4% |
Other | 16 | 6% |
Unknown | 45 | 17% |